Charleston, SC -- (SBWIRE) -- 12/30/2013 -- otcstockcenter.com, provide information specifically for trades in the micro cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Lets have a look on Few Hot Stocks: Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY), AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTCBB:AMBS), Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY).
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) closed latest trading day at $3.01, down-2.59 %, on volume of over8.95 million shares. The stock fell -4.14% in the last 5 days. Its average trading volume is 8.95 million shares. In the time frame of the last one month, the share-price has surged almost 13.58%. Its market capitalization was $3.49 billion. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support services in the secondary mortgage market in the United States.
What was the Moving Force behind FNMA On Bullish Run? Read This Research Report on GEN
With the latest riseof 0.91%, Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) now has YTD performance 12.84% . The total number of shares traded on the latest trading day was about342,154 shares, and changed hands at price range of $73.31 to $73.80apiece. Nestlé S.A., together with its subsidiaries, provides nutrition, health, and wellness products worldwide.
Has NSRGY Found The Bottom And Ready To Gain Momentum? Find Out Here
AMARANTUS BIOSCIENCE HOLDINGS, INC. (OTCBB:AMBS) reported the price of the stock moved up9.91 % and finished the day at $0.066 on above average volume. The total number of shares traded on the latest trading day was about 551,443 shares, and changed hands at price range of $0.0699 to $0.075 apiece. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States.
Why Should Investors Buy AMBS After the Recent Fall? Just Go Here and Find Out
Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) ended previous trading at $17.29, gaining 0.82%.The total number of shares traded on the latest trading day was about 1.56 million shares. In the last 5 days it showed a recovery/ of 10.69% and on its one month graph, shares are8.95% up. The stock has a 52-week high price of $17.33 and its 52-week low was recorded at $10.37. Deutsche Telekom AG operates as an integrated telecommunication company. The company offers fixed-network services, such as voice and data communication services based on fixed-network and broadband technology; and sells terminal equipment and other hardware, as well as services to resellers.
Will DTEGY Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)